Continuous Glucose Monitoring Initiation at Hospital Discharge
Stopped: High drop out rate
United States20 participantsStarted 2021-04-13
Plain-language summary
The purpose of this study is to look at feasibility (the likelihood) of continued use of the FreeStyle Libre 2 Continuous glucose monitor (CGM) when started at the time of hospital discharge in patients with poorly controlled diabetes and to look at the effects of CGM use on blood glucose control and quality of life. Additional information will be collected to determine the barriers to continuing CGM use after discharge. The investigators will also collect information to see how well blood glucose has been controlled after discharge while utilizing the CGM.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 18 years of age or older
✓. Have diabetes (type 1 diabetes mellitus, type 2 diabetes mellitus, cystic fibrosis related diabetes mellitus)
✓. Hemoglobin A1c greater than or equal to 8.0% or history of hypoglycemia unawareness
✓. Able and willing to sign informed consent form
✓. Have a valid telephone number
✓. Willing to purchase FreeStyle Libre 2 CGM sensors out of pocket after discharge from hospital (when insurance coverage isn't available)
Exclusion criteria
✕. Unable to sign informed consent form
✕. Have altered mental status
✕. Unable to manage diabetes independently at home
✕. Have utilized CGM in the past
✕
What they're measuring
1
To Determine the Feasibility of Initiating a Continuous Glucose Monitoring in Patients With Diabetes at Hospital Discharge